Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Raymond James Initiates Coverage On Unum with Market Perform Rating

Raymond James Initiates Coverage On Unum with Market Perform Rating

Raymond James analyst Wilma Burdis initiates coverage on Unum (NYSE:UNM) with a Market Perform rating.

byBenzinga Newsdesk

September 22, 2022

1 minute read

Raymond James analyst Wilma Burdis initiates coverage on Unum (NYSE:UNM) with a Market Perform rating.

Citigroup Maintains Neutral on Parker Hannifin, Raises Price Target to $360

By Benzinga Newsdesk

February 7, 10:43 AM

Citigroup analyst Timothy Thein maintains Parker Hannifin (NYSE:PH) with a Neutral and raises the price target from $320 to $360.

News

OPEC+ Girds For Contentious Meeting Over Oil-Production Cuts; OPEC To Discuss Production Cut Of Up To 1.5M Barrels A Day, Sources Say

By Benzinga Newsdesk

October 4, 3:49 PM

- Dow Jones Citing Wall Street Journal

USO

Smucker Gears Up For Q2 Print; Here’s A Look At Recent Price Target Changes By The Most Accurate Analysts

By Lisa Levin

December 1, 3:39 AM

The J. M. Smucker Company (NYSE: SJM) is projected to release financial results for its second quarter fiscal 2024, before the opening bell on Dec. 5, 2023.

SJM

Codexis Shares Up Following Reports China Is In Talks For Paxlovid Generic; Codexis In 2022 Announced Agreement With Pfizer To Supply Enzyme For The Manufacture Of Paxlovid

By Benzinga Newsdesk

January 6, 12:49 PM

https://www.codexis.com/investors/news-events/press-releases/detail/330/codexis-announces-agreement-with-pfizer-to-supply

BNTX

Raymond James Initiates Coverage On Unum with Market Perform Rating

Related Posts

Citigroup Maintains Neutral on Parker Hannifin, Raises Price Target to $360

OPEC+ Girds For Contentious Meeting Over Oil-Production Cuts; OPEC To Discuss Production Cut Of Up To 1.5M Barrels A Day, Sources Say

Smucker Gears Up For Q2 Print; Here’s A Look At Recent Price Target Changes By The Most Accurate Analysts

Codexis Shares Up Following Reports China Is In Talks For Paxlovid Generic; Codexis In 2022 Announced Agreement With Pfizer To Supply Enzyme For The Manufacture Of Paxlovid